Angle Share Discussion Threads

[dibs61] 15/1/2023 15:42

dexdringle so what do you think Global Frontier Investments know then with their due diligence?

[hsdeo] 15/1/2023 14:08

yeah then why is another company buying up shares. nice try!!

[dexdringle] 15/1/2023 13:00

It is an odd one this.

On the face of it, the share price has moved in a contra direction to the progress and likely demand.

Even more strange is Aegon bailing right at the point of success. They must think they know something we don't....

[robizm] 15/1/2023 13:00

Poor little kid no life at all.

[parob] 15/1/2023 12:48

Much better, less risky opportunity now compared to when Jupiter dumped late 2020. No FDA approval and years away from commercial deals then compared to now with FDA approval and never been closer to deals.

[davemac3] 15/1/2023 12:39

you would think a company with a FDA approved device for harvesting CTCs would be in on some of this action!!

[purchaseatthetop] 15/1/2023 12:27

Repeat of Jupiter which enabled me to buy originally at 40p. Which I thought was amazing until recently!

[parob] 15/1/2023 12:15

Big upside potential and minimal downside risk at this level imo.The more I research global frontier investments, the more comfortable I feel about holding here. Aegon's dump of all their shares has given PIs an amazing opp to buy at 11 year lows whilst the company has never been as advanced.

[bones698] 15/1/2023 11:02

Hi sandy I'm glad you enjoyed them . Didn't always seem many did lol

AN thinks he has all the time in the world sometimes which I don't believe is the case and certainly not investors either . Also the longer it takes there so always the chance we get left behind while others benefit . Even if their tech is inferior they vain maekket traction and become the norm..

On the plus side we seek to have increased revenue this year a lot if the figures are to be believed form 1m to 3.9m and we're only 1.1m short of the target before that rns and that's without any more deals getting signed . So I can see mofe to come and a beating market expectations rns at some point if AN can deliver just a few more deals .

At these levels it's a bargain and indeed little risk for the next year or so holding with plenty cash and a lot of possible news it's a no brainer for me and as you know I have been vebry critical of the company for a long time .

We are currently seeing a change in the uk approach to cancer diagnostics that's the reason I wonder if we got involved as Biontec seen to have got a foot in the door and hope we at least have tried again .

The US market was always going to be a tough one to get into ,I hope I get proven wrong and he manages it.

The UK nhs is a basket case and I can understand the problem pinning it down to someone to make a decision but atm tight now that sector is being mentioned a lot and is red hot . I can't see why Angle can't get in there if AN is even looking though . That's my concern he's always been focused on the US anyway imo and seems we missed the oppurtuniity here .

He better make the US work then imo and so far I'm not seeing that much at all but this year is crucial ,a lot more than I think he realizes. I do hope to see a few more deals at least and then an explosive rns bsagung we are going to beat revenue targets which will see us we'll over 100p again .

[millwallfan] 15/1/2023 10:42

I sincerely hope the AN and his team are working day and night to get some e contracts over the line as this is now highly embarrassing both financially and professionally.

[robizm] 15/1/2023 10:23

I think the NHS would rather purchase the parsortix machines and use them themselves to carry out tests as would most hospitals. This was the original plan to market the tech. The business model changed towards Angle carrying out the tests for much better margins rather than selling the machines and making money off the cartridges.

Parsortix should have been running alongside biopsies in UK and worldwide hospitals for years and the relationships built up with the NHS and other worldwide healthcare providers would now be easier to commercialise.

We all want to make money but this machine should be saving lives. The tech will be bettered one day and those patents don’t last forever.

Nearly 8 months after FDA nobody is kicking the door down to use the tech and I am scratching my head wondering why.

[radderssandy] 15/1/2023 08:25

Bones I’m glad you are back invested and posting regularly, I enjoy your posts.

AN was rather gloomy about prospects with the NHS in an article with the FT on the 3rd June last year. In the article AN said Angle had worked with top UK cancer research centres such as Barts Cancer Institute, but would like to roll the test out more extensively across the health service, where it has been “very, very difficult to gain traction”.

“Unfortunately, we failed miserably. We tried. But we’re finding all the traction is coming on the United States side, which is very disappointing. We can even provide this test at relatively low cost . . . but it’s just impossible to find anybody who’s able to make a decision.”

However, in more recent presentations AN has seemed a bit more upbeat. In the results presentation AN said that since achieving “FDA product clearance we've seen the first mover advantage coming through quite strongly. So we've had greater interest from third parties, medtech companies, pharmaceutical companies and even government.” (Although there was nothing to say it was the UK Gov).

AN was also asked a question in the Shares presentation about if there was any interest showing from national hospitals & health systems in Parsortix. He replied “ Yes, and I'm pleased to say that we were beginning to get engaged in the UK as well as United States and Germany. So that is a good good step….”

But we all know how bogged down in red tape the NHS is and it must be a nightmare trying to get any decisions pushed through.

[bones698] 15/1/2023 06:58

Disappointing with all this focus and media on the subject but no mention of agl . Newland is focused in the wrong market as usual . The UK is perfect to get in early and make a name as it's about saving money for the nhs . The US is different as it's money driven and the don't want to cut costs but get them hugher . Sadly that's how their system works .

Still think agl will do ok but we seek to be slow to the party especially here in the uk . Just hope some deals get signed soon after CLIA as that seems to be where AN is focusing after talking to big bio

[joinednow] 15/1/2023 05:23

The day I tried revolutionary new health MOT that can spot most cancers years before symptoms emerge.

Telegraph health editor have liquid biopsies.

[eeza] 14/1/2023 21:47

Liquid biopsies gaining traction.

[asdb9] 14/1/2023 18:11

Astra. The purpose of this forum is to share and discuss thoughts on Parsortix. Not a social media tool to troll other contributors.Time for a bit of membership cleaning I think

[kimchi1] 14/1/2023 16:15

Reading through the posts here it seems there are only ultra bulls and ultra bears around ! Bought in on Monday and did take some decent profits during the week, it is a risky AIM stock after all ...
There is definitely huge potential here, though as the trading RNS stated it could take a little while longer.
Despite the price having been much higher, at current price the market cap is 80m+ for 1m of Revenue and a large operating loss. The cash balance is large after the fundraise but the cash spend/outflow is as well, approx 1 years worth of cash left I think.
One to hold as a speculative investment, but don't bet the house on it IMHO.

[astra1vision] 14/1/2023 15:33

While AN is in charge of deals the only solid news you'll get is the type that pulls the price down. IMO ignore the paid rampers and PURCHASEATTHETOP, PAROB and their fast dwindling army and invest in safe stocks well away from AIM. You've got better odds at the Casino.

[bones698] 14/1/2023 15:31

That's fair enough good luck and don't sell too soon . There's newsflow coming and remember this has been over 150p last year and if anything things are looking a lot better now than they were then

[rajraj b] 14/1/2023 14:51

I bought in last week at 24 for a quick trade and sold out at 28 but now realise that was a mistake. I've bought back at 31 and am going long now. Just need some news to really get this motoring. Should do well.